Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Tesch

Showing results (181-190 of 282) with videos related to

Pageof 29
Sort By:
Clinical Science (London, England : 1979)|January 6, 2017
<i>miR-378</i> reduces mesangial hypertrophy and kidney tubular fibrosis via MAPK signallingBo Wang, Kevin Yao, Andrea F Wise, et al.
Immunology|August 26, 1998
Interleukin-10 differentially modulates MHC class II expression by mesangial cells and macrophages in vitro and in vivoS J Chadban, G H Tesch, R Foti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 17, 2012
Clinical experience with ferric carboxymaltose in the treatment of cancer- and chemotherapy-associated anaemiaT Steinmetz, B Tschechne, O Harlin, et al.
Cytokines and Molecular Therapy|December 1, 1996
Idiotype vaccination strategies against a murine B-cell lymphoma: dendritic cells loaded with idiotype and bispecific idiotype x anti-class II antibodies can protect against tumor growthH Bohlen, K Thielemanns, H Tesch, et al.
Frontiers in Physiology|March 1, 2021
c-Jun Amino Terminal Kinase Signaling Promotes Aristolochic Acid-Induced Acute Kidney InjuryFan Yang, Elyce Ozols, Frank Y Ma, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 4, 2009
Blockade of the c-Jun amino terminal kinase prevents crescent formation and halts established anti-GBM glomerulonephritis in the ratFrank Y Ma, Robert S Flanc, Greg H Tesch, et al.
Leukemia & Lymphoma|April 30, 1999
Dexa-BEAM is not effective in patients with relapsed or resistant aggressive high-grade non-Hodgkin's lymphomaM Reiser, A Josting, P Dias Wickramanayake, et al.
Frontiers in Physiology|January 23, 2023
Corrigendum: c-Jun amino terminal kinase signaling promotes aristolochic acid-induced acute kidney injuryFan Yang, Elyce Ozols, Frank Y Ma, et al.
Blood|July 27, 2001
STAT3 is constitutively activated in Hodgkin cell linesD Kube, U Holtick, M Vockerodt, et al.
Cancer Research|July 15, 1991
Patterns of DNA methylation in selected human genes in different Hodgkin's lymphoma and leukemia cell lines and in normal human lymphocytesS Achten, A Behn-Krappa, M Jücker, et al.
Pageof 29

Showing results (181-190 of 282) with videos related to

Sort By:
Pageof 29
Clinical Science (London, England : 1979)|January 6, 2017
<i>miR-378</i> reduces mesangial hypertrophy and kidney tubular fibrosis via MAPK signallingBo Wang, Kevin Yao, Andrea F Wise, et al.
Immunology|August 26, 1998
Interleukin-10 differentially modulates MHC class II expression by mesangial cells and macrophages in vitro and in vivoS J Chadban, G H Tesch, R Foti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 17, 2012
Clinical experience with ferric carboxymaltose in the treatment of cancer- and chemotherapy-associated anaemiaT Steinmetz, B Tschechne, O Harlin, et al.
Cytokines and Molecular Therapy|December 1, 1996
Idiotype vaccination strategies against a murine B-cell lymphoma: dendritic cells loaded with idiotype and bispecific idiotype x anti-class II antibodies can protect against tumor growthH Bohlen, K Thielemanns, H Tesch, et al.
Frontiers in Physiology|March 1, 2021
c-Jun Amino Terminal Kinase Signaling Promotes Aristolochic Acid-Induced Acute Kidney InjuryFan Yang, Elyce Ozols, Frank Y Ma, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 4, 2009
Blockade of the c-Jun amino terminal kinase prevents crescent formation and halts established anti-GBM glomerulonephritis in the ratFrank Y Ma, Robert S Flanc, Greg H Tesch, et al.
Leukemia & Lymphoma|April 30, 1999
Dexa-BEAM is not effective in patients with relapsed or resistant aggressive high-grade non-Hodgkin's lymphomaM Reiser, A Josting, P Dias Wickramanayake, et al.
Frontiers in Physiology|January 23, 2023
Corrigendum: c-Jun amino terminal kinase signaling promotes aristolochic acid-induced acute kidney injuryFan Yang, Elyce Ozols, Frank Y Ma, et al.
Blood|July 27, 2001
STAT3 is constitutively activated in Hodgkin cell linesD Kube, U Holtick, M Vockerodt, et al.
Cancer Research|July 15, 1991
Patterns of DNA methylation in selected human genes in different Hodgkin's lymphoma and leukemia cell lines and in normal human lymphocytesS Achten, A Behn-Krappa, M Jücker, et al.
Pageof 29